Mergers, acquisitions and strategic alliances in the pharmaceutical industry : Shareholders returns after the deal / Paola Quadri

0 review

Mergers, acquisitions and strategic alliances in the pharmaceutical industry : Shareholders returns after the deal / Paola Quadri

Study and report

QUADRI, Paola. Author

Published by ESCP Business School - 2011

Library: Madrid London Paris Champerret Paris Montparnasse Turin

Source : Syracuse

Item type

Study and report

Dissertation

MIM Master in Management Grande Ecole

Language

English

Publication year: 2011

Subjects: PHARMACEUTICAL INDUSTRY SECTOR - DEVELOPING COUNTRY - INVESTMENT - STRATEGIC ALLIANCE - MERGER AND ACQUISITION

This paper examines shareholders value creation in the pharmaceutical sector. A sample of 638 deals realised from developed-market acquirers between 1990 and 2010 is analysed. In a challenging market, more and more driven by the emerging-market countries, a huge increase of the market of generics has to be expected. To counterbalance these threats, Big Pharma companies start to acquire generics producers in developing countries. Furthermore, a future increase of Indian and Chinese pharmaceutical investments in developed countries is forecasted.